Cargando…
The cAMP-signaling cancers: Clinically-divergent disorders with a common central pathway
The cAMP-signaling cancers, which are defined by functionally-significant somatic mutations in one or more elements of the cAMP signaling pathway, have an unexpectedly wide range of cell origins, clinical manifestations, and potential therapeutic options. Mutations in at least 9 cAMP signaling pathw...
Autor principal: | Bolger, Graeme B. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9612118/ https://www.ncbi.nlm.nih.gov/pubmed/36313756 http://dx.doi.org/10.3389/fendo.2022.1024423 |
Ejemplares similares
-
Phosphodiesterases and cAMP Pathway in Pituitary Diseases
por: Bizzi, Mariana Ferreira, et al.
Publicado: (2019) -
Differential FSH Glycosylation Modulates FSHR Oligomerization and Subsequent cAMP Signaling
por: Agwuegbo, Uchechukwu T., et al.
Publicado: (2021) -
Chronic stress induces meiotic arrest failure and ovarian reserve decline via the cAMP signaling pathway
por: Jiang, Yiwen, et al.
Publicado: (2023) -
Role of EPAC in cAMP-Mediated Actions in Adrenocortical Cells
por: Lewis, Aurélia E., et al.
Publicado: (2016) -
PTH1R Actions on Bone Using the cAMP/Protein Kinase A Pathway
por: Martin, T. John
Publicado: (2022)